{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:59Z","timestamp":1791229499757,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.autrev.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T17:36:09Z","timestamp":1551720969000},"page":"493-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients"],"prefix":"10.1016","volume":"18","author":[{"given":"Mar\u00eda Asunci\u00f3n","family":"P\u00e9rez-Jacoiste As\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Rapha\u00ebl","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Br\u00e9zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pu\u00e9chal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2019.03.001_bb0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5152\/eurjrheum.2015.0043","article-title":"Updates in ANCA associated vasculitis","volume":"3","author":"Pagnoux","year":"2016","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0010","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","article-title":"Small-vessel vasculitis","volume":"337","author":"Jennette","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2019.03.001_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2019.03.001_bb0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2019.03.001_bb0025","doi-asserted-by":"crossref","first-page":"e6083","DOI":"10.1097\/MD.0000000000006083","article-title":"Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides. Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity","volume":"96","author":"Solans-Laque","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2019.03.001_bb0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.berh.2009.03.001","article-title":"The diagnosis of vasculitis","volume":"23","author":"Jayne","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000072990","article-title":"Current attitudes to the therapy of vasculitis","volume":"26","author":"Jayne","year":"2003","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.autrev.2019.03.001_bb0040","first-page":"1025","article-title":"Wegener's granulomatosis: the relationship between ocular and systemic disease","volume":"28","author":"Harper","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0045","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rdc.2010.05.005","article-title":"Ocular manifestations of ANCA-associated vasculitis","volume":"36","author":"Kubal","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2019.03.001_bb0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.semarthrit.2005.12.003","article-title":"Wegener's Granulomatosis: ophthalmic manifestations and management","volume":"35","author":"Pakrou","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.03.001_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11926-013-0355-x","article-title":"Ocular vasculitis","volume":"15","author":"Espinoza","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2019.03.001_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.survophthal.2009.12.003","article-title":"Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease","volume":"55","author":"Tarabishy","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.nephro.2009.05.003","article-title":"Ophtalmic manifestations in Wegener's granulomatosis. Review of literature about an observation","volume":"5","author":"Montagnac","year":"2009","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.autrev.2019.03.001_bb0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0002-9394(76)90784-4","article-title":"Ocular manifestations of Wegener's granulomatosis","volume":"44","author":"Straastsma","year":"1957","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10792-007-9109-y","article-title":"Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation","volume":"28","author":"Ahmed","year":"2008","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0161-6420(95)31065-2","article-title":"Disease relapse in patients with ocular manifestations of Wegener granulomatosis","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2019.03.001_bb0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.03.001_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"Ferrairo F, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jeanette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.03.001_bb0095","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.001_bb0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.001_bb0105","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.001_bb0110","first-page":"69","article-title":"The frequency of ophthalmologic manifestations of granulomatosis with polyangiitis (Wegener's) and their relationship to systemic diseases","volume":"89","author":"Isamilova","year":"2017","journal-title":"Ter Arkh"},{"key":"10.1016\/j.autrev.2019.03.001_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","article-title":"Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature","volume":"42","author":"Rothschild","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.03.001_bb0120","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener's granulomatosis with refractory granulomatous manifestations","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2019.03.001_bb0125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autrev.2017.11.014","article-title":"Childhood- versus adult-onset ANCA-associated vasculitides: a nested, matched case-control study from the French Vasculitis study group registry","volume":"17","author":"Iudici","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.03.001_bb0130","first-page":"455","article-title":"Grenzformen der periarteritis nodosa","volume":"42","author":"Klinger","year":"1931","journal-title":"Frankf Z Pathol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.03.001_bb0140","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/rheumatology\/kex261","article-title":"Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study","volume":"56","author":"Ungprasert","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2019.03.001_bb0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0161-6420(83)34574-7","article-title":"Ocular complications of Wegener's granulomatosis","volume":"90","author":"Bullen","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2019.03.001_bb0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/ICU.0b013e32834bdfe2","article-title":"Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis","volume":"22","author":"Schmidt","year":"2011","journal-title":"Curr Opin Ophthalmology"},{"key":"10.1016\/j.autrev.2019.03.001_bb0155","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/bjophthalmol-2015-307460","article-title":"Scleritis in patients with granulomatosis with polyangiitis (Wegener)","volume":"100","author":"Cocho","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0165","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.03.001_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-3083.2012.02747.x","article-title":"Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single Centre","volume":"76","author":"Pullerits","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","article-title":"Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations","volume":"71","author":"Holle","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.001_bb0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/rheumatology\/key117","article-title":"Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-center cohort study on 114 patients","volume":"58","author":"Pu\u00e9chal","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2019.03.001_bb0185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jamaophthalmol.2013.8179","article-title":"Rituximab therapy for refractory orbital inflammation: results of a phase 1\/2, dose-ranging, randomized clinical trial","volume":"132","author":"Suhler","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.autrev.2019.03.001_bb0190","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ophtha.2015.01.016","article-title":"Long-term outcomes of rituximab therapy in ocular granulomatosis with polyangiitis: impact on localized and nonlocalized disease","volume":"122","author":"Joshi","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2019.03.001_bb0195","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.autrev.2018.01.022","article-title":"Mortality in systemic necrotizing vasculitides: a retrospective analysis of the French Vasculitis Study Group registry","volume":"17","author":"Jardel","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:15:07Z","timestamp":1761599707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219300540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1568997219300540"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.03.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}